About this trial
The overarching goal of the proposed study is to determine the trajectories of physical recovery and cellular markers involved with the underlying failure to recover muscle after critical illness, while exploring which characteristics are associated with sustained physical disability. This proposal will examine muscle pathophysiology carefully aligned with physical function outcomes in order to longitudinally assess the recovery, or failed recovery, of muscle function in participants after critical illness:
1. to examine the recovery of muscle and physical function in ICU survivors through longitudinal assessments 2. to investigate the underlying cellular markers and mechanisms of muscle recovery in ICU survivors 3. to determine which cellular markers contribute to physical disability in ICU survivors up to 1 year after hospital admission
Eligibility criteria
Qualifiers
adult (>18 y/o)
admission for sepsis or acute respiratory failure with at least 72 hour stay in ICU
Disqualifiers
patients who were not ambulatory prior to ICU admission
experienced >2 ICU admissions in the past year (chronic or recurrent critical illness due to the same or different reason
patients not expected to survive ~6months after admission
acute or chronic neurologic condition
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Esther Dupont-Versteegden
Lead sponsor
University of Kentucky
Sponsor institution
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
Oklahoma Medical Research Foundation
Collaborator
University of Alabama at Birmingham
Collaborator